256.98USD-0.82%Mkt Cap: 618.61B $P/E: 29.78Today
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine…
Industry Peers
Drug Manufacturers - General$1.06TUSDP/E 42.3
$438.31BUSDP/E 121.0
$309.64BUSDP/E 21.3
$305.12BUSDP/E 34.8
$277.04BUSDP/E 22.2
$270.65BUSDP/E 22.0
$247.88BUSDP/E 25.8
$216.35BUSDP/E 25.5
$207.68BUSDP/E 11.8
$196.12BUSDP/E 25.3
$161.19BUSDP/E 17.7
$137.76BUSDP/E 18.5
$117.58BUSDP/E 16.1
$99.17BUSDP/E 19.3
$85.40BUSDP/E 13.8
$29.40BUSDP/E 21.4
MRV
Marvell Technology, Inc.$24.46BUSDP/E 9.3
$11.35BUSDP/E 22.7
$10.67BUSDP/E 18.5
$10.61BUSDP/E 18.4
$6.60BUSDP/E 14.6
$3.55BUSDP/E 14.5
$2.92BUSDP/E 17.8
$66.67MUSD
$38.85MUSD
ELXR
Elixxer Ltd.$9.51MUSD
CELG-RI
Bristol-Myers Squibb Company Ce—
—
FLXN
Horizon Flexible Income ETF—P/E 27.0
ROSE
DocMorris AG—
Indicators:|
Key Statistics
Company
Market Cap618.61B $
Enterprise Value656.65B $
Revenue (TTM)96.36B $
Gross Profit63.94B $
Net Income (TTM)26.80B $
Revenue/Share40.02 USD
Last Price256.98 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees138.2K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS4781601046
Valuation
P/E (Trailing)29.78
P/E (Forward)20.34
PEG5.06
EV/EBITDA19.13
EV/Revenue6.81
P/S6.47
P/B7.68
EPS (TTM)8.50
EPS (Forward)12.74
52W Range
154.8089% of range269.43
52W High269.43 USD
52W Low154.80 USD
Profitability
Gross Margin67.88%
Oper. Margin27.41%
EBITDA Margin35.62%
Profit Margin28.46%
ROE32.87%
ROA13.46%
Growth
Revenue Growth9.90%
Earnings Growth-52.90%
Cash Flow & Leverage
Operating CF24.53B $
CapEx (TTM)5.22B $
FCF Margin12.98%
FCF Yield2.02%
Net Debt32.94B $
Net Debt/EBITDA0.96
Balance Sheet
Debt/Equity0.59
Current Ratio1.02
Quick Ratio0.69
Book Value/Sh33.73 USD
Cash/Share9.160 USD
Dividends
Fwd Div Rate5.360 USD
Trail. Div Rate5.200 USD
Div. Yield2.03%
5Y Avg Yield2.77%
Payout Ratio60.25%
Ex-Div DateMay 26, 2026
Pay DateJun 9, 2026
Splits
Last Split2:1
Split DateJun 13, 2001
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)258.59 USD
Upside (mean)+0.6%
Target Range190.00 USD – 298.00 USD
$190.00+0.6% to mean$298.00
# Analysts22
Ownership
Shares Out.2.41B
Float2.40B
Insiders0.05%
Institutions76.87%
Short Interest
Short Ratio3.4d
Short % Float1.23%
Short % Out.1.11%
Shares Short26.69M
Short (prev mo.)23.04M
Technical
SMA 50235.53 (+9.1%)
SMA 200220.66 (+16.5%)
Beta0.23
S&P 52W Chg20.11%
Avg Vol (30d)6.55M
Avg Vol (10d)8.71M
Technical Indicators
RSI (14)59.8
MACD7.7232
MACD Signal6.8204
MACD Hist.+0.9029
BB Upper272.43 USD
BB Middle247.95 USD
BB Lower223.48 USD
BB Width19.74%
ATR (14)5.995 USD
Vol Ratio (20d)0.71x